Therefore, we assessed its role in LUAD prognosis and found that high TSHZ3 expression predicts a favorable outcome, reinforcing our hypothesis that TSHZ3 acts as a tumor suppressor in this cancer. The gene discussed is TSHZ3; the disease is neoplasm.